IP Basics

Kenyan Court Ruling Open New Prospects for Indian Generics Export Companies

Kenyan court’s recent orders can brighten up the generic drug makers’ prospects in African market. The Kenya High Court has ruled that the government must review Kenya’s Anti Counterfeit Act, 2008, a legislation that could threaten the import of generic medicines. The court has ordered the Kenyan government to make amendments to the Act [...]

By |2017-09-07T13:11:31+05:30May 2nd, 2012|IP Basics|0 Comments

Indian Pharma Companies: Emerging Generic Player

The Indian Pharma Companies has emerged as a strong generic player since the Indian Patent Act has been introduced in 1970. Earlier only process patents are allowed but from 2005 onwards India has shifted towards the product patent regime which has put the industry on a new growth trajectory. There are immense opportunities for [...]

By |2017-09-07T13:11:04+05:30May 1st, 2012|IP Basics, India|0 Comments

Patent Infringement Battle: Yahoo vs Facebook

Yahoo! Inc. is an American multinational internet corporation headquartered in Sunnyvale, California, United States. It is one of the largest websites in the United States. Since 1994 Yahoo! has grown to become a premiere digital media and communications company. With time Yahoo! Has diversified its product offerings beyond its original directory of websites. For [...]

By |2017-09-07T13:10:32+05:30April 30th, 2012|IP Basics, International|0 Comments

Tata Steel planning to license its intellectual property

As reported yesterday, Indian companies have started growing and maturing in terms of monetizing their intellectual property. Tata Steel which spends 1.5 % of total revenue in research and development is contemplating to earn money by licensing its intellectual property to other steel companies. At moment, Tata Steel is the world's seventh largest steel [...]

By |2017-09-07T13:10:04+05:30April 29th, 2012|IP Basics, India|0 Comments

How Biocon’s profit hit by loss of intellectual properly licensing income?

As reported by Mint, Biocon revenue up 16% but profit hit by loss of licensing. Licensing is surely important source of revenue generation. Biocon’s net profit has declined which is due to loss of licensing income from Pfizer, Divestment of Axicorp stake and licensing income from other partners such as Mylan Inc. Biocon and [...]

By |2017-09-07T13:09:40+05:30April 28th, 2012|International, IP Basics|0 Comments

Microsoft and Facebook finalized patent deal

Facebook is preparing for its May IPO and has spent money billion so far in buying patents from IBM, Instagram and now Microsoft. Microsoft Corporation and Facebook announced an agreement under which Facebook has agreed to purchase patents which Microsoft has recently bought for AOL for $550 million in cash. As per agreement, Facebook [...]

By |2017-09-07T13:09:09+05:30April 27th, 2012|IP Basics, Innovation|0 Comments
Go to Top